&nbsp;

FullDocumentClinicianResource-FR.pdf

Oct 2021

Regimen

AVD+BREN

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Funding:

New Drug Funding Program

Brentuximab Vedotin - In Combination with Chemotherapy for Previously Untreated Stage IV Hodgkin Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

AC(DD)

Cancer Type:

Breast

Intent: Neoadjuvant

Drugs Used:

DOXOrubicin,

cyclophosphamide

... Show more tags

Quick Link(s):

Regimen Monograph

Nov 2021

Guidelines and Advice

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Status: Current
ID: GL END 3-23
Version: N/A

Oct 2021

Apprentissage en ligne

Cancer facts

Active Transportation Varies Regionally

Jan 2022

Document

FormulaSedentaryTime-EN.JPG

Feb 2022

Document

FormulaSedentaryTime-FR.JPG

Feb 2022

Document

FITLabReportsPrimary.pdf

Mar 2022

Regimen

AC+PEMB

Cancer Type:

Breast

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2023

Regimen

ASCI

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

asciminib - For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, according to clinical criteria

Drugs Used:

asciminib

... Show more tags